CVR 45444651Private limited company (ApS)Ikke-finansielle holdingselskaber (642120)HøjbjergFounded 3 Mar 2025
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about BioMet ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexGross profit
-12.9K
DKK, annual report 2025
Result
-12.9K
DKK, annual report 2025
Equity
187.1K
DKK, annual report 2025
Lars Ditlev Mørck Ottosen25% to under 33.3% of capital and votes
Mads Ujarak Sieborg25% to under 33.3% of capital and votes
and 2 morePersonal holding company
Dandex estimate: NACE 642120, owned by persons without a majority ownerLars Ditlev Mørck Ottosensince 3 Mar 2025
Mads Ujarak Sieborgsince 3 Mar 2025
Michael Vedel Wegener Kofoedsince 3 Mar 2025
and 1 moreOwners of 5% or more. CVR registers shares in bands, not exact figures.
25% to under 33.3% of capital and votessince 3 Mar 2025
25% to under 33.3% of capital and votessince 3 Mar 2025
25% to under 33.3% of capital and votessince 3 Mar 2025
25% to under 33.3% of capital and votessince 3 Mar 2025
1 Danish company, which own 2 more one level down.
CVR 4625901725% to under 33.3% of capital and votes
CVR 44161729100% of capital and votes
CVR 4640857850% to under 66.7% of capital and votes
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR.
CVR 4416172925% to under 33.3% of capital and votes31 Mar 2025 to 12 Feb 2026
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Founded 3 Mar 2025.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2025 |
|---|---|
| Gross profit | -13 |
| Operating profit | -13 |
| Result for the year | -13 |
| Equity | 187 |
| Total assets | 193 |
| Employees (average) | 0 |
| Credit metrics (Dandex calculations) | |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
2025 covers 10 months (3 Mar to 31 Dec 2025).
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2025
3 Mar 2025 to 31 Dec 2025, published 25 Jun 2026
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for BioMet ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 180,000 | None | 180,000 | None | 200,000 | |
| FoundingCashPaid in 20,000 | None | 20,000 | None | 20,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
2 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 14.03.2025
Kapitalforhøjelsen er besluttet den 14.03.2025.
kr. 180.000,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 200.000,00.
Stiftelsesdato: 03.03.2025.
Virkningsdato: 03.03.2025.
Seneste vedtægtsdato: 03.03.2025.
Kapital:
kr. 20.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 20.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
Michael Vedel Wegener Kofoed, den 03.03.2025, Thomas Lundgaard, den 03.03.2025, Lars Ditlev Mørck Ottosen, den 03.03.2025, Mads Ujarak Sieborg, den 03.03.2025.
Direktion:
Michael Vedel Wegener Kofoed, den 03.03.2025, Thomas Lundgaard, den 03.03.2025, Lars Ditlev Mørck Ottosen, den 03.03.2025, Mads Ujarak Sieborg, den 03.03.2025.
Selskabet tegnes af 2 direktører i forening.
Første regnskabsår:
03.03.2025 - 31.12.2025.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at eje ejerandele i andre selskaber samt andre investeringer efter ledelsens skøn.
P-number 1031131150Kragelunds Allé 8, 8270 Højbjerg
No other current company drawn.
No other current company drawn.
No other current company drawn.